BRCA1 mutations confer upon women a breast cancer risk of about 60% and an ovarian cancer risk of about 40%; BRCA2 mutations confer a breast cancer risk of about 50% and an ovarian cancer risk of about 20% (Chen & Parmigiani, 2007). This evidence concerns the gene BRCA1 and ovarian carcinoma.